BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1403 related articles for article (PubMed ID: 26051126)

  • 1. Defensive remodeling: How bacterial surface properties and biofilm formation promote resistance to antimicrobial peptides.
    Nuri R; Shprung T; Shai Y
    Biochim Biophys Acta; 2015 Nov; 1848(11 Pt B):3089-100. PubMed ID: 26051126
    [TBL] [Abstract][Full Text] [Related]  

  • 2. On the in vivo significance of bacterial resistance to antimicrobial peptides.
    Bauer ME; Shafer WM
    Biochim Biophys Acta; 2015 Nov; 1848(11 Pt B):3101-11. PubMed ID: 25701234
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antimicrobial Peptides: Mechanisms of Action and Resistance.
    Bechinger B; Gorr SU
    J Dent Res; 2017 Mar; 96(3):254-260. PubMed ID: 27872334
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural variations of the cell wall precursor lipid II in Gram-positive bacteria - Impact on binding and efficacy of antimicrobial peptides.
    Münch D; Sahl HG
    Biochim Biophys Acta; 2015 Nov; 1848(11 Pt B):3062-71. PubMed ID: 25934055
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular determinants of bacterial sensitivity and resistance to mammalian Group IIA phospholipase A2.
    Weiss JP
    Biochim Biophys Acta; 2015 Nov; 1848(11 Pt B):3072-7. PubMed ID: 26079797
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antimicrobial peptides and their interaction with biofilms of medically relevant bacteria.
    Batoni G; Maisetta G; Esin S
    Biochim Biophys Acta; 2016 May; 1858(5):1044-60. PubMed ID: 26525663
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design and membrane-disruption mechanism of charge-enriched AMPs exhibiting cell selectivity, high-salt resistance, and anti-biofilm properties.
    Han HM; Gopal R; Park Y
    Amino Acids; 2016 Feb; 48(2):505-22. PubMed ID: 26450121
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antimicrobial peptide resistance in Neisseria meningitidis.
    Tzeng YL; Stephens DS
    Biochim Biophys Acta; 2015 Nov; 1848(11 Pt B):3026-31. PubMed ID: 26002321
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanisms of resistance to antimicrobial peptides in staphylococci.
    Joo HS; Otto M
    Biochim Biophys Acta; 2015 Nov; 1848(11 Pt B):3055-61. PubMed ID: 25701233
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insights into Peptide Mediated Antibiofilm Treatment in Chronic Wound: A Bench to Bedside Approach.
    Radhakrishnan MP; Suryaletha K; Shankar A; Savithri AV; George S; Thomas S
    Curr Protein Pept Sci; 2021; 22(1):50-59. PubMed ID: 33143623
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An intimate link between antimicrobial peptide sequence diversity and binding to essential components of bacterial membranes.
    Schmitt P; Rosa RD; Destoumieux-Garzón D
    Biochim Biophys Acta; 2016 May; 1858(5):958-70. PubMed ID: 26498397
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coevolution of Resistance Against Antimicrobial Peptides.
    Baindara P; Ghosh AK; Mandal SM
    Microb Drug Resist; 2020 Aug; 26(8):880-899. PubMed ID: 32119634
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative Evaluation of the Antimicrobial Activity of Different Antimicrobial Peptides against a Range of Pathogenic Bacteria.
    Ebbensgaard A; Mordhorst H; Overgaard MT; Nielsen CG; Aarestrup FM; Hansen EB
    PLoS One; 2015; 10(12):e0144611. PubMed ID: 26656394
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overview of ribosomal and non-ribosomal antimicrobial peptides produced by Gram positive bacteria.
    Tajbakhsh M; Karimi A; Fallah F; Akhavan MM
    Cell Mol Biol (Noisy-le-grand); 2017 Oct; 63(10):20-32. PubMed ID: 29096754
    [TBL] [Abstract][Full Text] [Related]  

  • 15. S. Typhimurium strategies to resist killing by cationic antimicrobial peptides.
    Matamouros S; Miller SI
    Biochim Biophys Acta; 2015 Nov; 1848(11 Pt B):3021-5. PubMed ID: 25644871
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bacterial strategies of resistance to antimicrobial peptides.
    Joo HS; Fu CI; Otto M
    Philos Trans R Soc Lond B Biol Sci; 2016 May; 371(1695):. PubMed ID: 27160595
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevention of ESKAPE pathogen biofilm formation by antimicrobial peptides WLBU2 and LL37.
    Lin Q; Deslouches B; Montelaro RC; Di YP
    Int J Antimicrob Agents; 2018 Nov; 52(5):667-672. PubMed ID: 29753132
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potential application of antimicrobial peptides in the treatment of bacterial biofilm infections.
    Strempel N; Strehmel J; Overhage J
    Curr Pharm Des; 2015; 21(1):67-84. PubMed ID: 25189860
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antimicrobial Peptides: Features, Action, and Their Resistance Mechanisms in Bacteria.
    Moravej H; Moravej Z; Yazdanparast M; Heiat M; Mirhosseini A; Moosazadeh Moghaddam M; Mirnejad R
    Microb Drug Resist; 2018; 24(6):747-767. PubMed ID: 29957118
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Using adjuvants and environmental factors to modulate the activity of antimicrobial peptides.
    Walkenhorst WF
    Biochim Biophys Acta; 2016 May; 1858(5):926-35. PubMed ID: 26751595
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 71.